PNN
Chennai (Tamil Nadu) [India], October 30: OMRON Healthcare Co., Ltd., a worldwide chief in clinically confirmed medical units for dwelling well being monitoring and therapy, as we speak introduced the graduation of full-scale blood strain monitor manufacturing on the OMRON Group’s first manufacturing facility in India, situated close to Chennai, Tamil Nadu. Operated by OMRON HEALTHCARE MANUFACTURING INDIA Pvt. Ltd., the power represents a big step within the firm’s growth of native manufacturing in India. To mark the launch of full-scale manufacturing, the manufacturing facility’s manufacturing operations have been opened to home and worldwide media and different stakeholders for the primary time.
Located at ORIGINS by Mahindra, the roughly 24,000-square-meter web site has 5 manufacturing traces manufacturing blood strain displays for the Indian market. Drawing on manufacturing applied sciences and quality-control experience developed at OMRON Healthcare’s Matsusaka manufacturing facility in Japan and its sister facility in Vietnam, the manufacturing facility manufactures the HEM-7090, HEM-7181, and HEM-7183T collection to the identical requirements of measurement accuracy and high quality as the corporate’s medical units provided to worldwide markets. Designed to satisfy the wants and value expectations of Indian shoppers, these vary from simple fashions for first-time customers to high-end units with options together with Trend Indicator, which alerts customers to will increase in blood strain readings, and Bluetooth connectivity with the OMRON Connect well being administration app. The manufacturing facility additionally helps the federal government’s Make in India initiative by native element sourcing, workforce improvement, and employment creation.
This milestone comes as India faces substantial cardiovascular healthcare challenges. Approximately 300 million folks nationwide are estimated to be residing with hypertension, whereas the World Health Organization (WHO) identifies cardiovascular ailments like stroke and coronary heart failure among the many nation’s main causes of demise. As India’s financial system continues to develop at roughly 7% yearly, way of life adjustments imply that the prevalence of hypertension is predicted to rise additional, including to such challenges and rising the necessity for preventive healthcare. Yet fewer than 5% of households have a house blood strain monitor in common use, whereas entry to healthcare companies additionally stays restricted in lots of areas. By strengthening the home provide of blood strain displays, OMRON Healthcare goals to assist extra widespread dwelling monitoring, earlier identification of cardiovascular dangers, and improved hypertension administration.
OMRON Healthcare has operated in India since 2010, elevating consciousness of hypertension and the significance of dwelling blood strain monitoring, supporting tutorial analysis, and collaborating with healthcare professionals and native companions to enhance cardiovascular care, together with working with the Indian Society of Hypertension on the event of India’s first dwelling blood strain monitoring tips. The firm goals to construct on these efforts by selling wider adoption of dwelling monitoring and strengthening connections between sufferers and healthcare professionals to assist earlier detection and forestall cardiovascular circumstances from worsening. Moving ahead, the corporate goals to extend the Chennai manufacturing facility’s manufacturing capability tenfold by 2028, to be able to guarantee a secure provide of blood strain displays for the Indian market, develop Chennai as a provide base for worldwide markets, and introduce nebulizer manufacturing for the therapy of respiratory circumstances reminiscent of bronchial asthma, strengthening the provision of dwelling healthcare units in India and past.
“Under the OMRON Group’s long-term vision, Shaping the Future 2030, we are working to address three key social challenges: achieving carbon neutrality, realizing a digital society, and extending healthy life expectancy. OMRON Healthcare’s role is to contribute to the third of these, helping people monitor their health as a natural part of everyday life and access appropriate medical care when needed,” mentioned Ayumu Okada, President and CEO, OMRON Healthcare Co., Ltd.
“As India’s economy develops, awareness of health management and preventive healthcare is growing, while timely detection and treatment of cardiovascular disease remain major challenges. Through products and services tailored to local needs, public awareness activities, support for academic research, and contributions to India’s first home blood pressure monitoring guidelines, we have worked to address these challenges.”
“The commencement of full-scale production in Chennai is an important step toward ensuring a stable supply of medical-grade blood pressure monitors in India. By strengthening local manufacturing and deepening collaboration with healthcare professionals and partners, we will continue to contribute to the Make in India initiative and support healthier lives for people across India.”
Blood Pressure Monitors Manufactured on the Chennai Factory
HEM-7183T Series:
Upper-arm blood strain monitor that includes Trend Indicator, an easy-to-wrap Fit Cuff, and Bluetooth connectivity with the OMRON Connect app.
HEM-7181 Series: Upper-arm blood strain monitor that includes Trend Indicator and a reminiscence operate for recording earlier measurements.
HEM-7090 Series: Standard upper-arm blood strain monitor designed for simple dwelling measurement, together with for first-time customers.
Chennai Factory – Key Facts
About OMRON Healthcare
Committed to advancing well being and empowering folks worldwide to stay life to the fullest, OMRON Healthcare is a worldwide chief within the discipline of clinically confirmed, modern medical gear for dwelling well being monitoring and therapy. Aiming to appreciate its imaginative and prescient, “Going for ZERO, Preventive Care for the Health of Society,” the corporate develops merchandise for cardiovascular situation administration, respiratory care, and ache remedy. Building on this, it has launched a brand new digital well being ecosystem that bridges sufferers and healthcare professionals, serving to to scale back cerebro-cardiovascular occasions, the worsening of respiratory ailments, and limitations attributable to power ache.
With over 400 million models offered globally*, OMRON has established a number one world presence in dwelling blood strain monitoring. Throughout its historical past, OMRON Healthcare has striven to enhance lives and contribute to a greater society by creating improvements that assist folks forestall, deal with, and handle their medical circumstances, offering services in over 130 international locations. OMRON Healthcare Group is headquartered in Kyoto, Japan.
* Cumulative gross sales of home-use digital blood strain displays worldwide. (as of September 2025)
For extra info, please go to:
Website: https://healthcare.omron.com/
LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/
Media inquiries
This press launch is disseminated by Kyodo PR on behalf of OMRON Healthcare.For extra info or for interview alternatives, please contact:
OMRON Healthcare Press Desk: [email protected]
(ADVERTORIAL DISCLAIMER: The above press launch has been offered by PNN. ANI won’t be accountable in any method for the content material of the identical.)